Meet
Features
Solutions
Pricing
Sales Intelligence
Qualify prospects and connect with decision makers effortlessly
Research Companies & Directors
Make important decisions with absolute confidence
Create B2B Marketing Lists
Target and reach more of your ideal prospects than ever
Monitor Risks & Opportunities
Be the first to learn about changes in the companies that matter
Cleanse Your B2B Database
Instantly transform old records into new opportunities
Perform KYC Checks
Completely understand who you're working with
Discover New Businesses
Identify and connect with new companies as soon as they register
Company Credit Reports
See how companies are performing year–on–year and explore their debts
UPGRADE
Mr Brenton Karl Ahrens
Mr Brenton Karl Ahrens was appointed in a total of 2 companies and resigned from 0 of these appointments.
Role
Director
Country Of Residence
United States
Nationality
American
Date of Birth
March 1963
Occupations
Venture Capital Investor • Blank
Active
2
Resigned
0
Dissolved
0
Other
0
Total
2
Companies
Company
Timeline
Status
Pathios Therapeutics Limited
Director • Venture Capital Investor
28 Aug 2019
←
6 Years
→
Current
Active
Grey Wolf Therapeutics Limited
Director • Blank
29 Mar 2018
←
7 Years
→
Current
Active
Mutual People
Thomas David McCarthy
Pathios Therapeutics Limited
and
Grey Wolf Therapeutics Limited
are mutual companies.
DR Stuart Wynn Hughes
Pathios Therapeutics Limited
is a mutual company.
Samantha ANN Harris
Grey Wolf Therapeutics Limited
is a mutual company.
DR Jeanmarie Guenot
Pathios Therapeutics Limited
is a mutual company.
DR Sally Marianne Dewhurst
Grey Wolf Therapeutics Limited
is a mutual company.
Someit Singh Sidhu
Pathios Therapeutics Limited
is a mutual company.
Financials, Credit Activity, Owners, and more
Completely understand the businesses you work with
Make key decisions on clients and suppliers faster, discover leads and connect with decision makers, and easily monitor opportunities that get better through time
EXPLORE ENDOLE APP